CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | SAYER KEVIN R Chairman, CEO & President | Sale | −2,323 | $376.05 | $874K | 140,879 |
| 2021-02-01 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,406 | $376.91 | $530K | 139,473 |
| 2021-02-01 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,350 | $378.11 | $510K | 138,123 |
| 2021-02-01 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,095 | $379.20 | $415K | 137,028 |
| 2021-02-01 | SAYER KEVIN R Chairman, CEO & President | Sale | −5,094 | $380.30 | $1.9M | 131,934 |
| 2021-01-27 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −500 | $359.70 | $180K | 18,578 |
| 2021-01-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −378 | $367.47 | $139K | 59,403 |
| 2021-01-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −310 | $368.88 | $114K | 59,093 |
| 2021-01-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −373 | $369.96 | $138K | 58,720 |
| 2021-01-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −18 | $372.77 | $7K | 58,702 |
| 2021-01-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −366 | $367.51 | $135K | 9,617 |
| 2021-01-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −169 | $368.20 | $62K | 9,448 |
| 2021-01-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −254 | $369.31 | $94K | 9,194 |
| 2021-01-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −310 | $370.24 | $115K | 8,884 |
| 2021-01-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −11 | $371.98 | $4K | 8,873 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,600 | $350.95 | $562K | 149,875 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −2,331 | $352.41 | $821K | 147,544 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,100 | $353.39 | $389K | 146,444 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −500 | $354.94 | $177K | 145,944 |
| 2021-01-13 | SAYER KEVIN R Chairman, CEO & President | Sale | −718 | $356.62 | $256K | 145,226 |
Page 42 of 55 · 1,082 trades